Yueqin Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yueqin Chen has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
Zhe Hu
Jining Med Univ, Clin Med Coll, Jining, Peoples R China
8 shared publicationsZhikang Tian
Jining Med Univ, 133 Hehua Rd, Jining 272067, Peoples R China
7 shared publicationsXi Wei
Jining Med Univ, 133 Hehua Rd, Jining 272067, Peoples R China
4 shared publicationsXiang Guo
Department of Radiology, the Affiliated Hospital of Jining Medical University, Jining, China
4 shared publicationsDeguo Liu
Department of Radiology, the Affiliated Hospital of Jining Medical University, Jining, China
3 shared publicationsJiehuan Wang
Department of Medical Imaging, Affiliated Hospital of Jining Medical University
3 shared publications
Latest Publications
- Open Access
- 11 February 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13
[18F]FDG PET/CT imaging in hyperthyroid myopathy presenting initially as myasthenia: a case report
Background: Muscle weakness can be a clinical manifestation of a wide range of diseases, often with an obscure etiology and a high risk of misdiagnosis. [ 18 F]FDG PET/CT has been widely studied in tumors and inflammatory myopathies; however, reports on [ 18 F]FDG PET/CT imaging of hyperthyroid myopathy are exceedingly rare, particularly in patients with a history of malignancy, in whom the diagnostic process is especially challenging. Case: A 51-year-old woman presented with bilateral lower-limb weakness of more than 1 year’s duration without an obvious precipitating factor. She had undergone surgery and chemotherapy for endometrial carcinoma 2 years earlier. Whole-body [ 18 F]FDG PET/CT demonstrated diffusely increased [ 18 F]FDG uptake in skeletal muscles throughout the body, with a maximum standardized uptake value (SUVmax) of 5.7. Both thyroid lobes were enlarged, with decreased density and diffusely increased [ 18 F]FDG uptake (SUVmax 3.1). Post-treatment changes of endometrial carcinoma were noted, with no evidence of metabolically active tumor recurrence or metastasis. Laboratory tests revealed elevated thyroid hormone levels and a thyroid-stimulating hormone level 18 F]FDG PET/CT shows diffuse hypermetabolism of skeletal muscles mimicking inflammatory myopathy, and concomitant abnormal thyroid metabolism is detected, hyperthyroid myopathy should be considered.
- 11 February 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13
Open Access[18F]FDG PET/CT imaging in hyperthyroid myopathy presenting initially as myasthenia: a case report
Background: Muscle weakness can be a clinical manifestation of a wide range of diseases, often with an obscure etiology and a high risk of misdiagnosis. [ 18 F]FDG PET/CT has been widely studied in tumors and inflammatory myopathies; however, reports on [ 18 F]FDG PET/CT imaging of hyperthyroid myopathy are exceedingly rare, particularly in patients with a history of malignancy, in whom the diagnostic process is especially challenging. Case: A 51-year-old woman presented with bilateral lower-limb weakness of more than 1 year’s duration without an obvious precipitating factor. She had undergone surgery and chemotherapy for endometrial carcinoma 2 years earlier. Whole-body [ 18 F]FDG PET/CT demonstrated diffusely increased [ 18 F]FDG uptake in skeletal muscles throughout the body, with a maximum standardized uptake value (SUVmax) of 5.7. Both thyroid lobes were enlarged, with decreased density and diffusely increased [ 18 F]FDG uptake (SUVmax 3.1). Post-treatment changes of endometrial carcinoma were noted, with no evidence of metabolically active tumor recurrence or metastasis. Laboratory tests revealed elevated thyroid hormone levels and a thyroid-stimulating hormone level 18 F]FDG PET/CT shows diffuse hypermetabolism of skeletal muscles mimicking inflammatory myopathy, and concomitant abnormal thyroid metabolism is detected, hyperthyroid myopathy should be considered.
- 3 June 2025
- Published by Elsevier in Academic Radiology
- Vol. 32 (7) , 4337-4338
Enhancing Preoperative Prediction of Lymphovascular Invasion in Rectal Cancer: The Role of Serum Tumor Markers
- 3 June 2025
- Published by Elsevier in Academic Radiology
- Vol. 32 (7) , 4337-4338
Enhancing Preoperative Prediction of Lymphovascular Invasion in Rectal Cancer: The Role of Serum Tumor Markers
- Open Access
- 1 December 2024
- Published by AME Publishing Company in Gland Surgery
- Vol. 13 (12) , 2300-2312
Development and validation of a radiomics-based nomogram for predicting two subtypes of HER2-negative breast cancer
Background: Breast cancer is the most common malignant tumor among women, with an increasing incidence each year. The subtypes of human epidermal growth factor receptor 2 (HER2)-negative breast cancer, classified as HER2-low and HER2-zero based on HER2 receptor expression, show differences in clinical characteristics, therapeutic approaches, and prognoses. Distinguishing between these subtypes is clinically valuable as it can impact treatment strategies, including the use of next-generation antibody-drug conjugates (ADCs) targeting HER2-low tumors. This study aimed to develop a nomogram based on dynamic magnetic resonance imaging (MRI) and clinical indicators to differentiate between HER2-low and HER2-zero subtypes in HER2-negative breast cancer patients. Methods: This study included 214 breast cancer patients from two centers, Hospital A (Affiliated Hospital of Jining Medical University, n=178) and Hospital B (Ningyang No. 1 People’s Hospital, n=36). HER2 status was determined by immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH). Among the participants, 112 cases were identified as HER2-low and 102 as HER2-zero. Patients from Hospital A were split into a training set and an internal test set in an 8:2 ratio, while the 36 patients from Hospital B were used as an external test set. Regions of interest (ROI) were delineated on phase 2 enhanced scans and diffusion weighted imaging (DWI) images, with features selected via Pearson correlation coefficients and least absolute shrinkage and selection operator (LASSO) regression. A K-Nearest Neighbor (KNN) model was employed to calculate the rad score, and clinical predictors (tumor maximum diameter and CA153) were identified through logistic regression analysis. These predictors, combined with the rad score, were incorporated into the final nomogram model. The model’s accuracy was evaluated using area under curve (AUC) values in both the internal and external validation sets. Results: The nomogram achieved AUC values of 0.873 and 0.859 in the internal and external validation sets, respectively, demonstrating superior performance over single-feature models. Decision curve analysis (DCA) indicated substantial net clinical benefits, and calibration curves displayed strong alignment between the model’s predictions and actual outcomes in both sets. Conclusions: This nomogram shows high accuracy and stability in differentiating HER2-low and HER2-zero subtypes among HER2-negative breast cancer patients, suggesting potential clinical utility in refining treatment decisions and identifying candidates for ADC therapy in HER2-low cases.
- 1 December 2024
- Published by AME Publishing Company in Gland Surgery
- Vol. 13 (12) , 2300-2312
Open AccessDevelopment and validation of a radiomics-based nomogram for predicting two subtypes of HER2-negative breast cancer
Background: Breast cancer is the most common malignant tumor among women, with an increasing incidence each year. The subtypes of human epidermal growth factor receptor 2 (HER2)-negative breast cancer, classified as HER2-low and HER2-zero based on HER2 receptor expression, show differences in clinical characteristics, therapeutic approaches, and prognoses. Distinguishing between these subtypes is clinically valuable as it can impact treatment strategies, including the use of next-generation antibody-drug conjugates (ADCs) targeting HER2-low tumors. This study aimed to develop a nomogram based on dynamic magnetic resonance imaging (MRI) and clinical indicators to differentiate between HER2-low and HER2-zero subtypes in HER2-negative breast cancer patients. Methods: This study included 214 breast cancer patients from two centers, Hospital A (Affiliated Hospital of Jining Medical University, n=178) and Hospital B (Ningyang No. 1 People’s Hospital, n=36). HER2 status was determined by immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH). Among the participants, 112 cases were identified as HER2-low and 102 as HER2-zero. Patients from Hospital A were split into a training set and an internal test set in an 8:2 ratio, while the 36 patients from Hospital B were used as an external test set. Regions of interest (ROI) were delineated on phase 2 enhanced scans and diffusion weighted imaging (DWI) images, with features selected via Pearson correlation coefficients and least absolute shrinkage and selection operator (LASSO) regression. A K-Nearest Neighbor (KNN) model was employed to calculate the rad score, and clinical predictors (tumor maximum diameter and CA153) were identified through logistic regression analysis. These predictors, combined with the rad score, were incorporated into the final nomogram model. The model’s accuracy was evaluated using area under curve (AUC) values in both the internal and external validation sets. Results: The nomogram achieved AUC values of 0.873 and 0.859 in the internal and external validation sets, respectively, demonstrating superior performance over single-feature models. Decision curve analysis (DCA) indicated substantial net clinical benefits, and calibration curves displayed strong alignment between the model’s predictions and actual outcomes in both sets. Conclusions: This nomogram shows high accuracy and stability in differentiating HER2-low and HER2-zero subtypes among HER2-negative breast cancer patients, suggesting potential clinical utility in refining treatment decisions and identifying candidates for ADC therapy in HER2-low cases.
- Open Access
- 13 November 2024
- Published by Springer Nature in Respiratory Research
- Vol. 25 (1) , 408
Letter to the editor: Incidence rate of occult lymph node metastasis in clinical T1 − 2N0M0 small cell lung cancer patients and radiomic prediction based on contrast-enhanced CT imaging: a multicenter study
- 13 November 2024
- Published by Springer Nature in Respiratory Research
- Vol. 25 (1) , 408
Open AccessLetter to the editor: Incidence rate of occult lymph node metastasis in clinical T1 − 2N0M0 small cell lung cancer patients and radiomic prediction based on contrast-enhanced CT imaging: a multicenter study
- 1 October 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 313 (1) , e233354
Clinical Effectiveness of Automated Coronary CT-derived Fractional Flow Reserve: A Chinese Randomized Controlled Trial
Automated coronary CT–derived fractional flow reserve was associated with reduced 90-day invasive coronary angiography rate without an increase in major adverse cardiac events up to 1 year.
- 1 October 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 313 (1) , e233354
Clinical Effectiveness of Automated Coronary CT-derived Fractional Flow Reserve: A Chinese Randomized Controlled Trial
Automated coronary CT–derived fractional flow reserve was associated with reduced 90-day invasive coronary angiography rate without an increase in major adverse cardiac events up to 1 year.
- 5 September 2024
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 43 (11) , 2217
Role of Ultrasound and Ultrasound‐Based Prediction Model in Differentiating Follicular Thyroid Carcinoma From Follicular Thyroid Adenoma
- 5 September 2024
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 43 (11) , 2217
Role of Ultrasound and Ultrasound‐Based Prediction Model in Differentiating Follicular Thyroid Carcinoma From Follicular Thyroid Adenoma
- Open Access
- 26 July 2024
- Published by SAGE Publications in Global Spine Journal
- Vol. 15 (2) , 1460
Letter to the Editor: Effectiveness of a Preoperative Bowel Preparation Protocol for Patients with Adolescent Idiopathic Scoliosis to Decrease Postoperative Gastrointestinal Morbidities and the Hospital Length of Stay
- 26 July 2024
- Published by SAGE Publications in Global Spine Journal
- Vol. 15 (2) , 1460
Open AccessLetter to the Editor: Effectiveness of a Preoperative Bowel Preparation Protocol for Patients with Adolescent Idiopathic Scoliosis to Decrease Postoperative Gastrointestinal Morbidities and the Hospital Length of Stay
- Open Access
- 1 June 2024
- Published by AME Publishing Company in Gland Surgery
- Vol. 13 (6) , 1150-1151
Analysis of risk factors related to the invasiveness of cN0 single papillary thyroid microcarcinoma
Analysis of risk factors related to the invasiveness of cN0 single papillary thyroid microcarcinoma
- 1 June 2024
- Published by AME Publishing Company in Gland Surgery
- Vol. 13 (6) , 1150-1151
Open AccessAnalysis of risk factors related to the invasiveness of cN0 single papillary thyroid microcarcinoma
Analysis of risk factors related to the invasiveness of cN0 single papillary thyroid microcarcinoma
- Open Access
- 1 June 2024
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 13 (6) , 3179-3180
Predicting papillary thyroid microcarcinoma in TI-RADS 3 nodules: a combined radiomics and clinical model
Predicting papillary thyroid microcarcinoma in TI-RADS 3 nodules: a combined radiomics and clinical model
- 1 June 2024
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 13 (6) , 3179-3180
Open AccessPredicting papillary thyroid microcarcinoma in TI-RADS 3 nodules: a combined radiomics and clinical model
Predicting papillary thyroid microcarcinoma in TI-RADS 3 nodules: a combined radiomics and clinical model